MR pre ReClip/surgery >2+, n (%) |
14 (100) |
10 (100) |
13 (100) |
26 (100) |
>0.999 |
MR post ReClip/surgery |
0 |
1.5 [1-2]* |
0 |
2 [1.5-2]* |
<0.001 |
TMVG post ReClip, mmHg |
/ |
4.0 [2.2-4.0]* |
/ |
3.8 [3.0-5.0]* |
0.71 |
TAPSE post ReClip/surgery, mm |
14±3 |
20±5 |
15±2 |
16±4 |
0.005 |
Duration until reintervention, months |
1.3 [0.9-12]* |
12 [2-19]* |
0.4 [0.2-1.4]* |
4 [0.8-13]* |
<0.001 |
Total LOS, days |
17.0 [15.0-21.0]* |
6.5 [4.5-14.5]* |
11.0 [8.0-25.0]* |
5.5 [4.0-7.8]* |
<0.001 |
Ventilation >48 hours, n (%) |
4 (31) |
1 (10) |
6 (46) |
1 (4) |
0.005 |
Stroke |
0 |
0 |
0 |
0 |
>0.999 |
Post acute kidney injury‡ (yes), n (%) |
2 (14) |
1 (10) |
3 (23) |
2 (8) |
0.597 |
Post-intervention blood transfusion (yes), n (%) |
13 (93) |
1 (10) |
12 (92) |
2 (8) |
<0.001 |
Intrahospital death, n (%) |
0 |
1 (10) |
5 (39) |
3 (11) |
0.036 |
Discharge status |
Home |
4 (29) |
6 (60) |
2 (15) |
21 (81) |
<0.001 |
Rehabilitation clinic |
10 (71) |
3 (30) |
6 (46) |
2 (8) |
<0.001 |
Numbers after frequencies are percentages. ‡ Stage II or III modified RIFLE criteria. *Median [IQR]. LOS: in-hospital length of stay after reintervention; TMVG: transmitral valve gradient |